S
CRL icon

Sachetta’s Charles River Laboratories CRL Stock Holding History

Sachetta’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-4
Closed -$690 – 1067
2026
Q1 		$690 Buy
+4
New +$742 ﹤0.01% 999
2025
Q2 		– Sell
-17
Closed -$2.56K – 1119
2025
Q1 		$2.56K Buy
17
+13
+325% +$2.18K ﹤0.01% 726
2024
Q4 		$739 Sell
4
-11
-73% -$2.12K ﹤0.01% 1037
2024
Q3 		$2.96K Hold
15
– – ﹤0.01% 775
2024
Q2 		$3.68K Hold
15
– – ﹤0.01% 665
2024
Q1 		$3.55K Hold
15
– – ﹤0.01% 585
2023
Q4 		$3.55K Buy
+15
New +$2.95K ﹤0.01% 585

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Sachetta's CRL Position: Q2 2026 in Review

Sachetta sold out of Charles River Laboratories (CRL) in Q2 2026, closing a stake of 4 shares — an estimated $690 sold.

Sachetta first reported a position in CRL in Q4 2023 and held it in 7 quarters. The position peaked at $3.68K in Q2 2024. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Sachetta reported no remaining Charles River Laboratories position as of Q2 2026 after selling out during the quarter.
  • Sachetta sold 4 Charles River Laboratories shares in Q2 2026, an estimated $690.
  • Sachetta first reported a position in Charles River Laboratories in Q4 2023 and held it in 7 quarters.
  • Sachetta's Charles River Laboratories position peaked at $3.68K in Q2 2024.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.